Search Results 171-180 of 16057 for pharmacogenetics

  1. Implementing Genomic Medicine in a Federally Qualified Health Center to Characterize Healthcare Provider and Patients Experiences - Mayo Clinic

    About this study. The purpose of this study is to characterize healthcare provider experiences caring for Latino/a patients receiving PRS in a Federally ...

  2. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...

  3. A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer - Mayo Clinic

    This study will use proteomic and genomic profiling to analyze tumor tissue to see if treatment selected by this analysis will benefit patients. Participation ...

  4. Focus Areas - Department of Molecular Pharmacology and Experimental Therapeutics Research - Mayo Clinic Research

    The Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic has multiple laboratories exploring a range of research focus areas.

  5. Precision medicine for breast cancer - Mayo Clinic

    Learn how genetic testing can help customize your cancer treatment plan. Precision medicine is improving breast cancer diagnosis, treatment and prevention.

  6. A Study of Phenotypic and Genetic Analysis of Vascular Overgrowth Syndromes - Mayo Clinic

    About this study. The purpose of this research is to develop a better understanding of the cause of vascular overgrowth syndromes and to develop a ...

  7. A Study Next Generation Sequencing (NGS) that May Help Identify Useful Genetic Information in Patients with Genetic Kidney Disease - Mayo Clinic

    The purpose of this study approach aims to identify exomic alterations that contribute to the development of kidney disease. Participation eligibility.

  8. Cardiac Channelopathies - Sudden Death Genomics: Michael J. Ackerman - Mayo Clinic Research

    The Ackerman Sudden Death Genomics Lab at Mayo Clinic is studying cardiac channelopathies related to long QT syndrome and catecholaminergic polymorphic ...

  9. Validation of Gene Expression Markers of Renal Allograft Functional Decline - Mayo Clinic

    About this study. Researchers would like to see if it is possible to predict which transplanted kidneys will do better long term based on the gene ...

  10. To combat heart disease and cancer, genomics researcher looks abroad - Mayo Clinic News Network

    Global collaboration is needed to make sure that a new type of genetic test, the polygenic risk score, performs equitably among people from diverse groups.